Scottish Device Hits 87.5% Success Rate for IV Access

Imagine needing chemotherapy but dreading the needle sticks more than the treatment itself. A Scottish medical device company just made that anxiety a little easier to manage.

Airglove Medical launched version 2 of its air warming system after six years of successful trials across more than 150 UK hospitals. The device gently warms a patient's arm using heated air circulated through a double-walled glove, dilating veins and making them easier to access.

The results speak for themselves. In oncology departments at NHS Maidstone and Tunbridge Wells, nurses achieved 87.5% first-attempt success rates using Airglove. That's remarkable considering cancer patients often have the most difficult veins to access due to repeated treatments.

The numbers reveal why this matters so much. Healthcare workers attempt 32 million IV insertions every year in the UK alone. Nearly one in three fails on the first try, meaning patients endure multiple needle sticks while nurses face workflow delays and mounting stress.

Major cancer centers have already adopted the system. Royal Marsden Cancer Centre, Guy's and St Thomas' Hospital, and St Barts Hospital all participated in the trials that led to this second-generation launch. The device earned official introduction at the UKONS nursing conference in Birmingham.

The Ripple Effect

The impact extends beyond successful needle sticks. Jason Ram, CEO at Airglove Medical, emphasizes protecting "precious veins" throughout a patient's treatment journey. Each failed attempt damages veins, making future access even harder and adding psychological stress to physical discomfort.

Healthcare workers benefit too. Fewer failed attempts mean smoother workflows, less procedure delays, and reduced anxiety for staff who hate causing unnecessary pain. Early feedback shows both nurses and patients appreciate the difference.

The technology itself is refreshingly straightforward. No complex electronics or expensive components, just warm air and basic physics applied to a persistent clinical problem. Sometimes the most elegant solutions are the simplest ones.

This worldwide patented system now enters the broader market with proven results backing its promise. For millions facing regular IV treatments, a warmer welcome might make all the difference.